Liver disease after the fontan procedure: What the hepatologist needs to know

Journal of Clinical Gastroenterology

Volumn 44, Issue 6, 2010, Pages 428-431

  Shah, Hiral ^a   Kuehl, Karen ^b   Sherker, Averell H ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

cirrhosis; congenital heart disease; Fontan; hepatologist; liver

Indexed keywords

CONGENITAL HEART DISEASE; FONTAN PROCEDURE; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; MEDICAL SPECIALIST; PATIENT CARE; PRIORITY JOURNAL; REVIEW; ADULT; CARDIOLOGY; GASTROENTEROLOGY; HEART DEFECTS, CONGENITAL; HEART VENTRICLE; INFANT; INTEGRATED HEALTH CARE SYSTEM; LIVER DISEASES; UNITED STATES;

ADULT; CARDIOLOGY; DELIVERY OF HEALTH CARE, INTEGRATED; FONTAN PROCEDURE; GASTROENTEROLOGY; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; LIVER DISEASES; UNITED STATES;

EID: 77953809813     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181d476fc     Document Type: Review

References (39)

1. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol. 2005;46:1-8.
2. Abarbanell GL, Goldberg CS, Devaney EJ, et al. Early surgical morbidity and mortality in adults with congenital heart disease: the University of Michigan experience. Congenit Heart Dis. 2008;3:82-89.
3. Srinathan SK, Bonser RS, Sethia B, et al. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart. 2005;91:207-212.
4. Peters NS, Somerville J. Arrhythmias after the Fontan procedure. Br Heart J. 1992;68:199-204.
5. Dobell AR, Trusler GA, Smallhorn JF, et al. Atrial thrombi after the Fontan operation. Ann Thorac Surg. 1986;42:664-667.
6. Marino BS. Outcomes after the Fontan procedure. Curr Opin Pediatr. 2002;14:620-626.
7. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26:240-248.
8. Castaneda AR. From Glenn to Fontan. A continuing evolution. Circulation. 1992;86(suppl 5):II80-II84.
9. Narkewicz MR, Sondheimer HM, Ziegler JW, et al. Hepatic dysfunction following the Fontan procedure. J Pediatr Gastroenterol Nutr. 2003;36:352-357.
10. Mayer JE Jr, Bridges ND, Lock JE, et al. Factors associated with marked reduction in mortality for Fontan operations in patients with single ventricle. J Thorac Cardiovasc Surg. 1992; 103:444-451; discussion 451-452.
11. Kaulitz R, Luhmer I, Bergmann F, et al. Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart. 1997;78:154-159.
12. Cohen AJ, Cleveland DC, Dyck J, et al. Results of the Fontan procedure for patients with univentricular heart. Ann Thorac Surg. 1991;52:1266-1270; discussion 1270-1271.
13. Lemmer JH, Coran AG, Behrendt DM, et al. Liver fibrosis (cardiac cirrhosis) five years after modified Fontan operation for tricuspid atresia. J Thorac Cardiovasc Surg. 1983;86:757-760.
14. Behrendt DM, Rosenthal A. Cardiovascular status after repair by Fontan procedure. Ann Thorac Surg. 1980;29:322-330.
15. Van Nieuwenhuizen RC, Peters M, Lubbers LJ, et al. Abnormalities in liver function and coagulation profile following the Fontan procedure. Heart. 1999;82:40-46.
16. Dunn GD, Hayes P, Breen KJ, et al. The liver in congestive heart failure: a review. Am J Med Sci. 1973;265:174-189.
17. Kotin P, Hall EM. "Cardiac" or congestive cirrhosis of liver. Am J Pathol. 1951;27:561-571.
18. Myers RP, Cerini R, Sayegh R, et al. Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations. Hepatology. 2003;37:393-400.
19. Kiesewetter CH, Sheron N, Vettukattill JJ, et al. Hepatic changes in the failing Fontan circulation. Heart. 2007;93:579-584.
20. Reynolds TB, Ito S, Iwatsuki S.Measurement of portal pressure and its clinical application. Am J Med. 1970;49:649-657.
21. Kendall TJ, Stedman B, Hacking N, et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol. 2008;61:504-508.
22. Arcidi JM Jr, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic study of 1000 subjects at autopsy. Am J Pathol. 1981;104:159-166.
23. Hsia TY, Khambadkone S, Redington AN, et al. Effects of respiration and gravity on infradiaphragmatic venous flow in normal and Fontan patients. Circulation. 2000;102(19 suppl 3):III148-III153.
24. Tomita H, Yamada O, Ohuchi H, et al. Coagulation profile, hepatic function, and hemodynamics following Fontan-type operations. Cardiol Young. 2001;11:62-66.
25. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005;129: 1348-1352.
26. Brancatelli G, Federle MP, Grazioli L, et al. Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol. 2002;178:877-883.
27. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991;22:172-178.
28. de Leval MR. The Fontan circulation: a challenge to William Harvey? Nat Clin Pract Cardiovasc Med. 2005;2:202-208.
29. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-714.
30. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999;341:866-870.
31. Rosenthal DN, Friedman AH, Kleinman CS, et al. Thromboembolic complications after Fontan operations. Circulation. 1995;92(suppl 9):II287-II293.
32. Jacobs ML, Pourmoghadam KK. Thromboembolism and the role of anticoagulation in the Fontan patient. Pediatr Cardiol. 2007;28:457-464.
33. Monagle P, Karl TR. Thromboembolic problems after the Fontan operation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2002;5:36-47.
34. Silvilairat S, Cabalka AK, Cetta F, et al. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Congenit Heart Dis. 2008;3:262-268.
35. Lin WS, Hwang MS, Chung HT, et al. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases. Chang Gung Med J. 2006;29:505-512.
36. Vyas H, Driscoll DJ, Cetta F, et al. Gastrointestinal bleeding and protein-losing enteropathy after the Fontan operation. Am J Cardiol. 2006;98:666-667.
37. Kanter RJ, Garson A Jr. Atrial arrhythmias during chronic follow-up of surgery for complex congenital heart disease. Pacing Clin Electrophysiol. 1997;20:502-511.
38. Babatin M, Lee SS, Pollak PT. Amiodarone hepatotoxicity. Curr Vasc Pharmacol. 2008;6:228-236.
39. Lewis JH, Ranard RC, Caruso A, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology. 1989;9:679-685.